Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-16

Clinical Trial Update: Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy [Phase 2]

View source ↗

Summary

A Phase II trial investigates hepatic arterial infusion of albumin-bound paclitaxel (nab-paclitaxel) combined with nedaplatin for advanced/metastatic breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nab-paclitaxel (paclitaxel protein-bound)
  • Nedaplatin (nedaplatin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Hepatic Artery Infusion, Liver Metastasis of Breast Cancer | Phase 2 | Status: RECRUITING